Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial
- Hungria, V.
- Beksac, M.
- Weisel, K.C.
- Nooka, A.K.
- Masszi, T.
- Spicka, I.
- Munder, M.
- Mateos, M.-V.
- Mark, T.M.
- Qi, M.
- Qin, X.
- Fastenau, J.
- Spencer, A.
- Sonneveld, P.
- Garvin, W.
- Renaud, T.
- Gries, K.S.
ISSN: 1365-2141, 0007-1048
Year of publication: 2021
Volume: 193
Issue: 3
Pages: 561-569
Type: Article